Keywords: Multiple Sclerosis, Multiple Sclerosis, .
Motivation: Multiple Sclerosis patients present cognitive decline at the early stages of the disease. Current neurocognitive batteries may not identify early changes. FA evaluates microstructural changes in white matter. To consider clinicopathological correlation remains complex and needs to be understood.
Goal(s): A biomarker that could detect patients with cognitive deficits might benefit from early diagnosis and treatment.
Approach: ML to identify subcortical white matter biomarkers between Healthy Controls with Cognitive Preserved and Relapsing-Remitting Multiple Sclerosis patients with or without cognitive impairment in verbal episodic memory.
Results: We found six FA biomarkers, all located in the frontal lobes. These features maximized the accuracy, obtained: 62.22±17.33%.
Impact: Since the MRI is the gold standard for MS diagnosis, we can obtain new insights about not only the patient's condition but also detect early changes in patients with cognitive impairment.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords